Search
Selected Filter
Displaying 51–60 of 508 news results
-
Foundation News
Advancing Research Solutions for PRPH2-Associated Retinal Diseases.
-
Foundation Fighting Blindness to Host VISIONS 2024 Conference
Foundation NewsThe global conference, held on June 21–22, is dedicated to fostering connection, learning, and empowerment for individuals and families impacted by blinding diseases.
-
Research News
No serious adverse events were reported. One patient had encouraging improvement in retinal sensitivity.
-
Foundation News
Empowering Healthcare Providers and Patients with Genetic Testing and Genetic Counseling Solutions
-
ARVO 2024 Highlight: New Gene Linked to RP in People with African Ancestry
Research NewsThe discovery will help geneticists diagnose more RP patients with African descent.
-
ARVO 2024 Highlight: Positive Two-Year Results from PDE6B Gene Therapy Clinical Trial
Research NewsMutations in PDE6B are a leading cause of retinitis pigmentosa.
-
Atsena’s XLRS Gene Therapy Shows Efficacy in Phase 1/2 Clinical Trial
Research NewsThe XLRS gene therapy was well tolerated and resolved damaging schisis cavities in patients receiving the lowest dose.
-
Foundation Fighting Blindness To Host Annual 2024 Gala Night for Sight
Foundation NewsThe May 9th gala will raise awareness and fund research leading to treatments and cures for blinding diseases.
-
SalioGen Developing Novel Gene Insertion Therapy for Stargardt Disease
Research NewsThe company’s innovative Gene Coding™ platform enables seamless insertion of DNA into selective genomic locations.
-
Phase 3 Clinical Trial of NAC Launched for RP Patients
Research NewsThe drug is thought to work independent of the mutated gene causing RP.
